Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1696 studies found for:    "Parkinson Disease"
Show Display Options
Rank Status Study
21 Active, not recruiting Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
Condition: Parkinsons Disease
Intervention:
22 Completed Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline
23 Completed
Has Results
Pioglitazone in Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Pioglitazone;   Drug: placebo
24 Recruiting Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention:
25 Active, not recruiting Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: ROTIGOTINE
26 Not yet recruiting Neural Correlates of Cognition in Parkinson's Disease
Condition: Parkinson Disease
Interventions: Behavioral: Computer task assessing cognition;   Behavioral: Impulsive-Compulsive Disorders in Parkinson's Disease;   Behavioral: Montreal Cognitive Assessment
27 Enrolling by invitation Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Device: Deep brain stimulation;   Other: Electroencephalography
28 Completed Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
Condition: Parkinson's Disease
Intervention: Drug: ONO-2506PO
29 Withdrawn Use of Zolpidem in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Levodopa;   Drug: Zolpidem first dose;   Drug: Zolpidem second dose;   Drug: sugar pill
30 Completed Enteric Nervous System in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Procedure: Biopsies
31 Completed Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)
Condition: Parkinson's Disease
Interventions: Drug: Safinamide;   Drug: Placebo
32 Completed
Has Results
A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Placebo to Preladenant Tablet;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo to Rasagiline capsule
33 Completed Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: levodopa-carbidopa
34 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649 (pitolisant)
35 Completed Glutathione (GSH) In The Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Glutathione
36 Completed Aquatic Therapy Versus Land-Based Therapy for the Treatment of Balance Dysfunction in Parkinson's Disease
Condition: Parkinson Disease
Interventions: Other: MIRT-AT;   Other: MIRT
37 Unknown  Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: duloxetine;   Drug: placebo of duloxetine;   Drug: injection of apomorphine;   Drug: injection of placebo of apomorphine;   Drug: L-Dopa;   Drug: injection of placebo of L-Dopa
38 Completed
Has Results
The Effect of Exercise on Individuals With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Behavioral: Progressive resistance training;   Behavioral: Modified Fitness Counts
39 Completed A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rotigotine
40 Completed
Has Results
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Condition: Parkinson's Disease
Interventions: Drug: Preladenant;   Drug: Placebo tablet to match Preladenant

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.